drugset / Trial / NCT00711477

A Study Using Functional Magnetic Resonance Imaging (fMRI) to Assess the Effects of Naltrexone SR/ Bupropion SR Therapy in Overweight or Obese Subjects

NCT00711477

Phase 2 Completed 46 enrolled Orexigen Therapeutics, Inc
RandomizedParallel-groupTriple-blindBasic science

Summary

The purpose of this study was to assess the effect of naltrexone SR/bupropion SR (NB) on brain function in response to food cues using functional magnetic resonance imaging in overweight or obese subjects.

Timeline

Start
2008-09
Primary completion
2010-06
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupropion Small molecule 360 mg
Subject Naltrexone Small molecule 32 mg

Indications